Sam Altman's Merge Labs Launches to Compete with Elon Musk's Neuralink
- Sam Altman, CEO of OpenAI, is co-founding brain-computer interface startup Merge Labs with Alex Blania, known for Worldcoin and Tools for Humanity
- Merge Labs plans to raise $250 million at an $850 million valuation and aims for less invasive, high-bandwidth brain-computer technology
- Altman brings credibility as a co-founder but will not manage daily operations or invest personal funds
- Merge Labs differentiates itself from Neuralink by targeting broader human–AI integration instead of only medical applications
- The global brain-computer interface market is projected to reach $12.87 billion by 2034
OpenAI CEO Sam Altman has co-founded Merge Labs, a brain-computer interface (BCI) startup that is preparing to compete with Elon Musk's Neuralink. Merge Labs, started with Alex Blania, aims to develop less invasive, high-bandwidth BCIs for human–AI integration and is seeking $250 million in funding at an $850 million valuation.
Merge Labs Launch and Strategy
Merge Labs was co-founded by Sam Altman and Alex Blania, with Altman bringing experience from OpenAI and Blania known for Worldcoin and digital identity projects. The company is positioning itself as a direct competitor to Neuralink, with a focus on creating brain-computer interfaces that enable broader human–AI interactions rather than just medical outcomes. Merge Labs is seeking $250 million in new funding, valuing the startup at approximately $850 million.[1][2][3]
Leadership and Operational Structure
Although Altman serves as a co-founder, he will not be involved in daily operations and will not be investing his personal capital in Merge Labs. Alex Blania will handle management responsibilities. Funding may also come from OpenAI’s venture capital arm, indicating organizational backing but limited direct oversight from Altman personally.[1][2][3]
Technology Approach and Market Context
Merge Labs distinguishes itself from Neuralink by pursuing less invasive, high-bandwidth interfaces to enable broad, non-medical applications, aiming to advance human–AI integration. Neuralink, founded by Elon Musk, has focused on medical technologies and recently raised $650 million at a $9 billion valuation. The BCI sector is forecasted to be worth $12.87 billion by 2034, reflecting broad investor and developer interest in the field.[1][3][4]
Further sources
The stories that matter, in one email. Free — unsubscribe anytime.